Pyxis Oncology Inc.

1.20
0.07 (6.19%)
At close: Feb 28, 2025, 3:59 PM
1.18
-1.67%
Pre-market: Mar 03, 2025, 04:11 AM EST

Pyxis Oncology Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 9.66M 179.29M 274.74M 8.08M 19.69M
Short-Term Investments 109.63M n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a 109K 109K 30K
Receivables 21K 598K n/a n/a n/a
Inventory n/a 874K n/a n/a n/a
Other Current Assets 5.29M 6.72M 3.94M 23K 11K
Total Current Assets 124.6M 186.61M 278.67M 8.1M 19.7M
Property-Plant & Equipment 24.81M 24.77M 1.24M 1.94M 76K
Goodwill & Intangibles 24.31M n/a n/a n/a n/a
Total Long-Term Assets 49.12M 24.77M 1.35M 2.05M 106K
Total Assets 173.73M 211.38M 280.02M 10.15M 19.81M
Account Payables 3.9M 7.1M 11.95M 1.08M 491K
Deferred Revenue 7.66M n/a 6.33M 1.95M 224K
Short-Term Debt 1.23M n/a 330K 615K 9K
Other Current Liabilities 12.97M 24.54M 6.43M 1.93M 124K
Total Current Liabilities 25.76M 31.63M 18.71M 3.69M 733K
Long-Term Debt 20.1M 18.92M n/a 165K 6K
Other Long-Term Liabilities n/a n/a n/a 21.94M 21.94M
Total Long-Term Liabilities 22.26M 18.92M n/a 22.11M 21.95M
Total Liabilities 48.02M 50.55M 18.71M 25.8M 22.68M
Total Debt 21.33M 18.92M 165K 780K 15K
Common Stock 45K 34K 32K 1K 1K
Retained Earnings -286.23M -212.44M -91.72M -15.74M -2.92M
Comprehensive Income 63K n/a -280.02M -21.94M -21.94M
Shareholders Equity 125.7M 160.82M 261.31M -15.64M -2.87M
Total Investments 109.63M n/a n/a n/a n/a